Literature DB >> 18535887

FDG positron emission tomography imaging of drug-induced pneumonitis.

Miwa Morikawa1, Yoshiki Demura, Shiro Mizuno, Shingo Ameshima, Takeshi Ishizaki, Hidehiko Okazawa.   

Abstract

Several studies have reported the findings of fluorine-18-labeled fluoro-2-deoxy-D: -glucose positron emission tomography (FDG-PET) in benign lung disease with diffuse pulmonary injury; however, the characteristics and effectiveness of FDG-PET imaging for interstitial pneumonitis have not been substantiated. We report two cases of drug-induced pneumonitis in two patients treated for breast cancer who were diagnosed by FDG-PET examination. Both the cases showed diffuse interstitial infiltration in the bilateral lungs on computed tomography, but the degree of FDG accumulation was different. It is probable that the degree of FDG accumulation reflected the activity of the drug-induced pneumonitis. The present cases show very interesting FDG-PET imaging findings of diffuse lung disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18535887     DOI: 10.1007/s12149-007-0109-9

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  3 in total

1.  Dual-time-point 18F-FDG PET imaging for diagnosis of disease type and disease activity in patients with idiopathic interstitial pneumonia.

Authors:  Yukihiro Umeda; Yoshiki Demura; Takeshi Ishizaki; Shingo Ameshima; Isamu Miyamori; Yuji Saito; Tatsuro Tsuchida; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-27       Impact factor: 9.236

2.  Drug induced interstitial lung disease.

Authors:  Martin Schwaiblmair; Werner Behr; Thomas Haeckel; Bruno Märkl; Wolfgang Foerg; Thomas Berghaus
Journal:  Open Respir Med J       Date:  2012-07-27

3.  Prospective Study of Drug-induced Interstitial Lung Disease in Advanced Breast Cancer Patients Receiving Everolimus Plus Exemestane.

Authors:  Annelieke E C A B Willemsen; Jolien Tol; Nielka P van Erp; Marianne A Jonker; Maaike de Boer; Bob Meek; Paul C de Jong; Coline van Moorsel; Winald R Gerritsen; Jan C Grutters; Carla M L van Herpen
Journal:  Target Oncol       Date:  2019-08       Impact factor: 4.493

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.